Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.

Autor: Sharma A; US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: asharma4@cdc.gov., Hill A; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Kurbatova E; US Centers for Disease Control and Prevention, Atlanta, GA, USA., van der Walt M; South Africa Medical Research Council, Pretoria, South Africa., Kvasnovsky C; University of Maryland Medical Center, Baltimore, MD, USA., Tupasi TE; Tropical Disease Foundation, Manila, Philippines., Caoili JC; Tropical Disease Foundation, Manila, Philippines., Gler MT; Tropical Disease Foundation, Manila, Philippines., Volchenkov GV; Vladimir Oblast Tuberculosis Dispensary, Vladimir, Russia., Kazennyy BY; Orel Oblast Tuberculosis Dispensary, Orel, Russia., Demikhova OV; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russia., Bayona J; Socios en Salud Sucursal, Lima, Peru., Contreras C; Socios en Salud Sucursal, Lima, Peru., Yagui M; National Institute of Health, Lima, Peru., Leimane V; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia., Cho SN; International Tuberculosis Research Center, Changwon and Yonsei University College of Medicine, Seoul, South Korea., Kim HJ; Korean Institute of Tuberculosis, Seoul, South Korea., Kliiman K; Tartu University Hospital, Tartu, Estonia., Akksilp S; Ministry of Public Health, Bangkok, Thailand., Jou R; Taiwan Centers for Disease Control, Taipei, Taiwan., Ershova J; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Dalton T; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Cegielski P; US Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2017 Jul; Vol. 17 (7), pp. 707-715. Date of Electronic Publication: 2017 May 09.

Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.

Autor: Yuen CM; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Kurbatova EV; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Tupasi T; Tropical Disease Foundation, Manila, Philippines., Caoili JC; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.; Tropical Disease Foundation, Manila, Philippines., Van Der Walt M; Medical Research Council, Pretoria, South Africa., Kvasnovsky C; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.; Medical Research Council, Pretoria, South Africa., Yagui M; National Institute of Health, Lima, Peru., Bayona J; Partners In Health, Boston, Massachusetts, United States of America., Contreras C; Socios en Salud Sucursal, Lima, Peru., Leimane V; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Riga, Latvia., Ershova J; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Via LE; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Kim H; Korean Institute of Tuberculosis, Seoul, Republic of Korea., Akksilp S; Department of Disease Control, Ministry of Public Health, Bangkok, Thailand., Kazennyy BY; Orel Oblast Tuberculosis Dispensary, Orel, Russian Federation., Volchenkov GV; Vladimir Oblast Tuberculosis Dispensary, Vladimir, Russian Federation., Jou R; Taiwan Centers for Disease Control, Taipei, Taiwan., Kliiman K; Tartu University Hospital, Tartu, Estonia., Demikhova OV; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russian Federation., Vasilyeva IA; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russian Federation., Dalton T; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Cegielski JP; Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Publikováno v: PLoS medicine [PLoS Med] 2015 Dec 29; Vol. 12 (12), pp. e1001932. Date of Electronic Publication: 2015 Dec 29 (Print Publication: 2015).

Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.

Autor: Kurbatova EV, Dalton T, Ershova J, Tupasi T, Caoili JC, Van Der Walt M, Kvasnovsky C, Yagui M, Bayona J, Contreras C, Leimane V, Via LE, Kim H, Akksilp S, Kazennyy BY, Volchenkov GV, Jou R, Kliiman K, Demikhova OV, Cegielski JP

Publikováno v: Emerging infectious diseases [Emerg Infect Dis] 2015 Jun; Vol. 21 (6), pp. 977-83.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Autor: Cegielski JP; Centers for Disease Control and Prevention, Atlanta, Georgia., Dalton T; Centers for Disease Control and Prevention, Atlanta, Georgia., Yagui M; National Institute of Health, Lima, Peru., Wattanaamornkiet W; Department of Disease Control, Ministry of Public Health, Bangkok, Thailand., Volchenkov GV; Vladimir Oblast Tuberculosis Dispensary, Russian Federation., Via LE; National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Van Der Walt M; Medical Research Council, Pretoria, Republic of South Africa., Tupasi T; Tropical Disease Foundation, Manila, Republic of the Philippines., Smith SE; Centers for Disease Control and Prevention, Atlanta, Georgia., Odendaal R; Medical Research Council, Pretoria, Republic of South Africa., Leimane V; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia., Kvasnovsky C; Centers for Disease Control and Prevention, Atlanta, Georgia., Kuznetsova T; Vladimir Oblast Tuberculosis Dispensary, Russian Federation., Kurbatova E; Centers for Disease Control and Prevention, Atlanta, Georgia., Kummik T; Tartu University Hospital, Estonia., Kuksa L; Riga East University Hospital Centre of Tuberculosis and Lung Diseases, Latvia., Kliiman K; Tartu University Hospital, Estonia., Kiryanova EV; Orel Oblast Tuberculosis Dispensary, Russian Federation., Kim H; Korean Institute of Tuberculosis, Seoul, Republic of Korea., Kim CK; Korean Institute of Tuberculosis, Seoul, Republic of Korea., Kazennyy BY; Orel Oblast Tuberculosis Dispensary, Russian Federation., Jou R; Taiwan Centers for Disease Control, Taipei., Huang WL; Taiwan Centers for Disease Control, Taipei., Ershova J; Centers for Disease Control and Prevention, Atlanta, Georgia., Erokhin VV; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow., Diem L; Centers for Disease Control and Prevention, Atlanta, Georgia., Contreras C; Socios en Salud Sucursal, Lima, Peru., Cho SN; International Tuberculosis Research Center, Changwon Yonsei University College of Medicine, Seoul, Republic of Korea., Chernousova LN; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow., Chen MP; Centers for Disease Control and Prevention, Atlanta, Georgia., Caoili JC; Tropical Disease Foundation, Manila, Republic of the Philippines., Bayona J; Socios en Salud Sucursal, Lima, Peru., Akksilp S; Department of Disease Control, Ministry of Public Health, Bangkok, Thailand.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2014 Oct 15; Vol. 59 (8), pp. 1049-63. Date of Electronic Publication: 2014 Jul 23.

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

Autor: Dalton T; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. tldalton@cdc.gov, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE 3rd, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P

Publikováno v: Lancet (London, England) [Lancet] 2012 Oct 20; Vol. 380 (9851), pp. 1406-17. Date of Electronic Publication: 2012 Aug 30.